[
  "FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder",
  "Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease"
]